Thomas Müller

Guardians of Health

Cellima Talks V

Thomas Müller
CELLIMA TALKS V

The study of ion channels in early drug discovery

Welcome to an exclusive interview with Thomas Müller, a renowned scientist with more than 30 years of experience in ion channel research.

Thomas Müller talks about his beginnings as a student in Heidelberg and Glasgow to his current position as Head of Cellular High Throughput Screening at Bayer. There he makes important decisions about the latest scientific developments and research projects.

Thomas takes us on a fascinating journey into the world of ion channels, giving us new and exciting insights into how these tiny structures play a crucial role in our everyday lives.

Thomas also introduces us to some exciting technologies that have helped us better understand how ion channels work. These include electrophysiology and optogenetics.

Whether you are an experienced researcher, a biology student, or just curious about the latest advances in science and medicine, we invite you to be inspired by the creative and exciting news in medical research.

The interview was recorded in German. 

We offer the original German version as well as a dubbed English version.

 

more insights

Marc Bickle

Deep Phenotyping And AlphaFold

Marc Bickle discusses how Deep Phenotyping and AlphaFold are transforming early-stage drug discovery. Learn about cutting-edge technologies that enhance precision in oncology and neurodegenerative research, offering new insights and accelerating the development of personalized therapies through advanced AI-driven methods and high-content imaging.

Read more >
Thomas Müller

Guardians of Health

Thomas Müller, a distinguished scientist with over 30 years’ experience in ion channel research, talks about his journey from studying biology in Heidelberg and Glasgow to leading high-throughput screening at Bayer, where he’s been at the forefront of scientific innovation. In this enlightening session, Thomas shares his remarkable journey and delves into the fascinating world of ion channels.

Read more >
Respondents

HCI 2024 – Prospects

In order to better describe the current state and future prospects of High-Content Imaging, a market survey was conducted among researchers and organizations involved in early drug discovery worldwide.

Read more >

Future Prospects of High-Content Imaging